IPO registrations (S-1, F-1) · Registrants

Tonix Pharmaceuticals Holding Corp.

SEC CIK
1430306 · filings on EDGAR ↗
Former names
TAMANDARE EXPLORATIONS INC. (2008–2011)
Registration
Form S-1, first filed 2008-04-09, last 2020-02-06; 11 initial registrations, 20 amendments
Outcome
Final prospectus filed 2018-12-10; declared effective 2008-04-18; withdrawal requested 2017-09-15
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
NV
Business address
200 CONNELL DRIVE, SUITE 3100, Berkeley Heights, NJ 07922
EIN
26-1434750
Ticker
TNXP (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Tonix Pharmaceuticals Holding Corp. on the corporate pages

Offering terms

Final price
$3.50 per share (424B4 filed 2018-12-10)
Shares sold
861,710
Gross proceeds
$3,015,985 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TNXP
Lead underwriters
A.G.P./Alliance Global Partners
Syndicate
Dawson James; Securities, Inc

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 55

FiledFormWhat it isName as filedEDGAR
2008-04-09S-1S-1 (registration)TAMANDARE EXPLORATIONS INC.0001165527-08-000188 ↗
2008-04-18EFFECTEFFECT (declared effective)TAMANDARE EXPLORATIONS INC.9999999995-08-001123 ↗
2012-04-26S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001144204-12-023973 ↗
2012-06-04S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-12-033044 ↗
2012-06-06EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-12-001737 ↗
2013-01-25S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001144204-13-004082 ↗
2013-03-22S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-016787 ↗
2013-04-02S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-019627 ↗
2013-04-05EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-13-000898 ↗
2013-05-10S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001144204-13-028032 ↗
2013-06-06S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-033676 ↗
2013-06-20S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-035795 ↗
2013-06-21S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-036153 ↗
2013-07-02S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-037798 ↗
2013-07-31S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-042075 ↗
2013-08-08S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001144204-13-044008 ↗
2013-08-08EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-13-002353 ↗
2014-01-08EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-14-000070 ↗
2014-04-23EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-14-001087 ↗
2014-04-23EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-14-001088 ↗
2014-08-15EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-14-002533 ↗
2017-09-15RWRW (withdrawal request)Tonix Pharmaceuticals Holding Corp.0001615774-17-005129 ↗
2017-09-29S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001615774-17-005489 ↗
2017-10-12EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-17-002671 ↗
2018-05-16EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-18-001273 ↗
2018-09-07S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001615774-18-009355 ↗
2018-10-24S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001615774-18-011280 ↗
2018-11-02S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001615774-18-011996 ↗
2018-11-05EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-18-002804 ↗
2018-12-03S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001615774-18-013697 ↗
2018-12-03S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001615774-18-013717 ↗
2018-12-06S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001615774-18-013865 ↗
2018-12-07EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-18-003062 ↗
2018-12-10424B4424B4 (final prospectus)Tonix Pharmaceuticals Holding Corp.0001615774-18-014150 ↗
2019-06-19S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001387131-19-004490 ↗
2019-07-01S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-004759 ↗
2019-07-11S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-004970 ↗
2019-07-15S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-005027 ↗
2019-07-15EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-19-001601 ↗
2019-07-16424B4424B4 (final prospectus)Tonix Pharmaceuticals Holding Corp.0001387131-19-005112 ↗
2019-08-23S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001387131-19-006373 ↗
2019-09-06S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-006791 ↗
2019-09-11EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-19-002067 ↗
2019-10-18S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001387131-19-007745 ↗
2019-11-14S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-008666 ↗
2019-11-14S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-19-008761 ↗
2019-11-14EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-19-002571 ↗
2019-11-18424B4424B4 (final prospectus)Tonix Pharmaceuticals Holding Corp.0001387131-19-008844 ↗
2020-01-21S-1S-1 (registration)Tonix Pharmaceuticals Holding Corp.0001387131-20-000350 ↗
2020-02-06S-1/AS-1/A (amendment)Tonix Pharmaceuticals Holding Corp.0001387131-20-001063 ↗
2020-02-06EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-20-000276 ↗
2020-02-11424B4424B4 (final prospectus)Tonix Pharmaceuticals Holding Corp.0001387131-20-001265 ↗
2020-04-17EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-20-000785 ↗
2021-01-04EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-21-000028 ↗
2021-05-05EFFECTEFFECT (declared effective)Tonix Pharmaceuticals Holding Corp.9999999995-21-001798 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2018-12-06S-1/Aregistration statement$139.422,132,701$297,341,173Nasdaq TNXP3primary document; price line, shares headline, proceeds computed, cover names 3document ↗
2018-12-10424B4final prospectus$3.50861,710$3,015,985Nasdaq TNXP3primary document; price sentence, shares headline, proceeds computed, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Moss David JDirector,Officer,TenPercentOwnerPRES, CEO, TRES, CFO, SECR22010–2011person page Fuzzy
DAUGHERTY BRUCEOfficerSee remarks; See Remarks; SEE REMARKS152013–2016
DAVIDSON STUARTDirector102013–2017
GERSHELL LELANDOfficerCFO and Treasurer; Chief Financial Officer162013–2015
GRACE PATRICK PDirector122013–2019
LANDRY DONALD WDirector122013–2019person page Fuzzy
LEDERMAN & CO., LLCTenPercentOwner12013
LEDERMAN SETHDirector,Officer; Director,Officer,TenPercentOwner; OfficerChief Executive Officer; President and CEO622013–2026
MARIO ERNESTDirector342013–2018
MATHER CHARLES E IVDirector172013–2018
Rhodes John BDirector192013–2020
Saks Samuel RDirector162013–2018
KELLERMAN DONALD JOfficerSee Remarks32014
SULLIVAN GREGORY MOfficerChief Medical Officer292014–2026
MORRIS JESSICA EDGAROfficerActing Chief Financial Officer; Chief Administrative Officer; Chief Operating Officer162015–2026
SAENGER BRADLEYOfficer; Officer,TenPercentOwnerChief Financial Officer222016–2026
Bell Margaret SmithDirector122017–2026
GRANGE DAVID LDirector112018–2026
OLUKOTUN ADEOYE YDirector122018–2026
Treco JamesDirector152019–2026
Goodman Daniel WintnerDirector52019–2021
BAGGER RICHARD HDirector112020–2026person page Fuzzy
Taylor Carolyn E.Director92021–2026
Stillwell Richard NewcombDirector72023–2026
Fogarty SiobhanOfficerChief Technology Officer32025–2026
Hunter James Randolph JrDirector32025–2026
Englese ThomasOfficerChief Commercial Officer12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2017-10-10Tonix Pharmaceuticals Holding Corp.Pharmaceuticals$15,314,798$314,79811
2012-01-31Tonix Pharmaceuticals Holding Corp.Pharmaceuticals$10,000,000$4,302,950811

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationTONIX PHARMACEUTICALS HOLDING CORP.NJState business registriesname and state
Form D issuerTonix Pharmaceuticals Holding Corp.NYForm D private offeringsCIK (EXACT)
Lobbying clientTONIX PHARMACEUTICALS HOLDING CORP.NJFederal lobbying (LDA)name and state
SEC filerTonix Pharmaceuticals Holding Corp.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorTONIX PHARMACEUTICALS HOLDING CORP.EIN (EXACT)
Person pageDavid J MossPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner)
Person pageDonald W LandryPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageRichard H BaggerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NJ first:

More with this interest.

In other datasets, the same topic (Health) in NJ:

Interests: Pharmaceutical Preparations · Health